NASDAQ: AVDL
Avadel Pharmaceuticals PLC Stock

$8.00-0.33 (-3.96%)
Updated Feb 6, 2025
AVDL Price
$8.00
Fair Value Price
-$0.12
Market Cap
$770.89M
52 Week Low
$7.39
52 Week High
$19.09
P/E
-10.53x
P/B
10.32x
P/S
9.14x
PEG
N/A
Dividend Yield
N/A
Revenue
$138.16M
Earnings
-$72.58M
Gross Margin
91.9%
Operating Margin
-45.25%
Profit Margin
-52.5%
Debt to Equity
1.12
Operating Cash Flow
-$83M
Beta
0.98
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

AVDL Overview

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine AVDL's potential to beat the market

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Pharmaceutical

Industry Rating
B
AVDL
Ranked
Unranked of 63

Top Ranked Stocks in Industry

View Top Pharmaceutical Stocks

Be the first to know about important AVDL news, forecast changes, insider trades & much more!

AVDL News

Overview

Due Diligence Score

Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AVDL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AVDL ($8.00) is overvalued by 6,766.62% relative to our estimate of its Fair Value price of -$0.12 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
AVDL ($8.00) is not significantly undervalued (6,766.62%) relative to our estimate of its Fair Value price of -$0.12 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AVDL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AVDL due diligence checks available for Premium users.

Valuation

AVDL fair value

Fair Value of AVDL stock based on Discounted Cash Flow (DCF)

Price
$8.00
Fair Value
-$0.12
Undervalued by
6,766.62%
AVDL ($8.00) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AVDL ($8.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AVDL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AVDL price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-10.53x
Industry
9.55x
Market
31.69x

AVDL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
10.32x
Industry
2.22x
AVDL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AVDL's financial health

Profit margin

Revenue
$50.0M
Net Income
-$2.6M
Profit Margin
-5.2%
AVDL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AVDL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$158.3M
Liabilities
$83.6M
Debt to equity
1.12
AVDL's short-term assets ($127.26M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AVDL's short-term assets ($127.26M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AVDL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AVDL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.9M
Investing
$4.9M
Financing
$1.2M
AVDL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AVDL vs Pharmaceutical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
AVDL$770.89M-3.96%-10.53x10.32x
CRON$772.24M-1.46%-16.83x0.71x
EOLSC$849.14M-1.18%-14.90x144.17x
EBSA$566.77M-3.86%-2.66x1.11x
TLRYF$993.91M-0.93%-3.53x0.29x

Avadel Pharmaceuticals Stock FAQ

What is Avadel Pharmaceuticals's quote symbol?

(NASDAQ: AVDL) Avadel Pharmaceuticals trades on the NASDAQ under the ticker symbol AVDL. Avadel Pharmaceuticals stock quotes can also be displayed as NASDAQ: AVDL.

If you're new to stock investing, here's how to buy Avadel Pharmaceuticals stock.

What is the 52 week high and low for Avadel Pharmaceuticals (NASDAQ: AVDL)?

(NASDAQ: AVDL) Avadel Pharmaceuticals's 52-week high was $19.09, and its 52-week low was $7.39. It is currently -58.09% from its 52-week high and 8.25% from its 52-week low.

How much is Avadel Pharmaceuticals stock worth today?

(NASDAQ: AVDL) Avadel Pharmaceuticals currently has 96,361,528 outstanding shares. With Avadel Pharmaceuticals stock trading at $8.00 per share, the total value of Avadel Pharmaceuticals stock (market capitalization) is $770.89M.

Avadel Pharmaceuticals stock was originally listed at a price of $1.81 in Dec 31, 1997. If you had invested in Avadel Pharmaceuticals stock at $1.81, your return over the last 27 years would have been 341.26%, for an annualized return of 5.65% (not including any dividends or dividend reinvestments).

How much is Avadel Pharmaceuticals's stock price per share?

(NASDAQ: AVDL) Avadel Pharmaceuticals stock price per share is $8.00 today (as of Feb 6, 2025).

What is Avadel Pharmaceuticals's Market Cap?

(NASDAQ: AVDL) Avadel Pharmaceuticals's market cap is $770.89M, as of Feb 7, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Avadel Pharmaceuticals's market cap is calculated by multiplying AVDL's current stock price of $8.00 by AVDL's total outstanding shares of 96,361,528.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.